• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Drugs - Images
Drugs - Images

... • Humans have used drugs of one sort or another for thousands of years -wine was used at least from the time of the early Egyptians -narcotics from 4000 BC -medicinal use of marijuana has been dated to 2737BC in China ...
Atypical Antipsychotic Drugs: Clozapine, olanzapine
Atypical Antipsychotic Drugs: Clozapine, olanzapine

... partial agonist at the 5-HT1A receptor, which produces synergistic effects with 5-HT2A receptor antagonism. Most are either 5-HT6 or 5-HT7 receptor antagonists. Pharmacokinetics: Most of the antipsychotic drugs are readily but incompletely absorbed, many undergo significant first-pass metabolism. Mo ...
Introduction to Pharmacology
Introduction to Pharmacology

... – Described as “what the body does to the drug” – Includes the processes of absorption, distribution, metabolism and elimination ...
PATIENT`S NAME: MEDICATION - McGraw-Hill
PATIENT`S NAME: MEDICATION - McGraw-Hill

... the legs, lungs, brain, and eyes), nausea, breakthrough menstrual bleeding, spotting, changes in menstrual flow, lack of menstruation, swelling, bloating, weight changes, changes to uterine opening, uterine secretions, yellowing of eyes or skin, fever, and allergic reactions (including hair loss, ra ...
Generic Pharmaceutical Products: Same Quality
Generic Pharmaceutical Products: Same Quality

... In Canada, brand name drugs have 20 years of patent protection. During that time, only the patent holder can produce the drug, but after that, other manufacturers can apply to Health Canada to produce generic versions. When Health Canada approval is given, governments, private insurance plans and co ...
JUN 1 2 2001 . ,s`
JUN 1 2 2001 . ,s`

... This is in response to your letter of May 14, 2007 to the Food and Drug Administration (FDA) pursuant to 21 U.S.C. 343(r)(6) (section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act (the Act)) . Your notice states that Wellness International Network, Ltd, is making the claim "Support healthy l ...
2-Renal tubular excretion
2-Renal tubular excretion

... • 3-Inhibitors of intestinal P-glycoprotein: • -P-glycoprotein (P-gp) is an important modulator of intestinal drug transport (expel drugs from intestinal mucosa into the lumen). • -Inhibition of (P-gp) (similar to enzyme inhibition) will lead to increase bioavailability of certain drugs. • -P-gp in ...
Drugs - Kaleem Rasheed
Drugs - Kaleem Rasheed

... -morphine ...
Drug Classes for Hig..
Drug Classes for Hig..

... from Hypertension Online, please contact us at ccit@bcm.tmc.edu . ...
Synthetic Drugs What every parent and caregiver needs to know
Synthetic Drugs What every parent and caregiver needs to know

... new legislation that bans known synthetic drugs Often sold as “bath salts” or “incense” and other common household products to mask intended use Each package can have a unique and potentially more harmful effect than product sold in identical packaging ...
Pharmacokinetics
Pharmacokinetics

... onto the bone-crystal surface and eventually become incorporated into the crystal lattice. Bone then can become a reservoir for slow release of toxic agents (e.g., lead, radium) into the blood. ...
life.nthu.edu.tw
life.nthu.edu.tw

... • 1940, Howard Florey: “enough evidence, ….., has now been assembled to show that penicillin is a new and effective type of chemotherapeutic agent, and possesses some properties unknown in any antibacterial substance hitherto described.” • Pfizer - mass production during World War II. ...
CHEMICAL MESSENGERS
CHEMICAL MESSENGERS

... neurons to fire but still occupy site, preventing other chemicals from sitting there ex. _______________________________________ ___________________________________________ ___________________________________________ ...
Pharmacology Objectives 5
Pharmacology Objectives 5

... enhancing elimination. Polymorphism of NAT2 results in people with slow and people with rapid acetylation of certain drugs (e.g. isoniazid, hydralazine, and dapsone). Slow acetylators of isoniazid may develop a peripheral neuropathy due its blocking of pyridoxal phosphokinase (required for myelin sh ...
SMU-DDE-Assignments-Scheme of Evaluation PROGRAM Bachelor
SMU-DDE-Assignments-Scheme of Evaluation PROGRAM Bachelor

... elimination of drugs and are of great practical importance in the choice and administration of a particular drug for a particular patient, e.g., one with impaired renal function. In practical therapeutics, a drug should be able to reach its intended site of action after administration by some conven ...
Book Review - Portsmouth Research Portal
Book Review - Portsmouth Research Portal

... psychopharmaceuticals are based on cynicism towards biomedicine’s “magic bullet” (p.7) model of drug effects. The book has been written from “a position of doubt about the immediate and long-term side effects of biomedical psychopharmaceuticals” (p.187). Mistrust of bio-medical drugs focus on their ...
Pharmacokinetic drug interaction
Pharmacokinetic drug interaction

... gastric conditions in the stomach ,Drugs that increase gastric pH (e.g.,H2 antagonists, proton pump inhibitors) slow the dissolution of the solid dosage forms and decrease drug available for absorption in the gastric lumen. GIT motility: Drugs that increase gastric emptying or intestinal motility, s ...
21 Viagra
21 Viagra

... Drug companies, however, are hardly struggling to beat back the wolves of bankruptcy. The pharmaceutical sector racks up the largest legal profits of any industry, and it is expected to grow by an average of 16 to 18 percent over the next four years, about three times more than the average for the F ...
Drug Discovery and Development
Drug Discovery and Development

... disease which only affects a small subset of the  population) ...
Review: lower dose combination antihypertensive therapy is
Review: lower dose combination antihypertensive therapy is

... balance drug effectiveness with minimal side effects, to help policy makers in identifying similarly effective drugs so that maximum patient benefit can be achieved at the lowest cost (ie, facilitate reference based pricing), and to provide researchers with critical normative data against which to c ...
Drugs may be indirect to pathogenesis
Drugs may be indirect to pathogenesis

... Some human GPCRs involved in aging and certain age-related pathologies ...
CHEMICAL MESSENGERS
CHEMICAL MESSENGERS

... stimulation and reward; this pathway is dopamine-rich; • most drugs produce changes in this system, but “broccoli” (food) does not produce dramatic changes… Why not? ...
Slide 1
Slide 1

... Saliva : Dermatitis ( some intravenous drugs ) Mammilary glands : pH= 6.5 Morphine ...
Slide 1
Slide 1

... Saliva : Dermatitis ( some intravenous drugs ) Mammilary glands : pH= 6.5 Morphine ...
Psych 260
Psych 260

... (With the exception of the last question, each question is worth 1 pt. Write your answers for the last questions directly on the quiz, and hand it in along with your scantron. Be sure to put your name on both the scantron and your quiz!) 1. ___________ refers to the process by which drugs are absorb ...
< 1 ... 149 150 151 152 153 154 155 156 157 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report